Myocyte signalling in leucocyte recruitment to the heart

Cardiovascular Research

Volumn 102, Issue 2, 2014, Pages 270-280

  Ghigo, Alessandra ^a   Franco, Irene ^a   Morello, Fulvio ^b   Hirsch, Emilio ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b MOLINETTE HOSPITAL   (Italy)

Author keywords

Cardiac inflammation; Cytokines; Heart disease; Leucocyte recruitment; Signalling pathways

Indexed keywords

DNA FRAGMENT; HEAT SHOCK PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE;

HEART; HEART FAILURE; HEART INFARCTION; HEART MUSCLE; HEART MUSCLE CELL; INFLAMMATION; INTRACELLULAR SIGNALING; LEUKOCYTE; MYOCARDITIS; PRESSURE; PRIORITY JOURNAL; REVIEW; ANIMAL; HUMAN; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; CYTOKINES; HUMANS; INFLAMMATION; LEUKOCYTES; MYOCARDIAL INFARCTION; MYOCYTES, CARDIAC; SIGNAL TRANSDUCTION;

EID: 84899089737     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvu030     Document Type: Review

References (95)

1. Wrigley BJ Lip GY Shantsila E. The role of monocytes and inflammation in the pathophysiology of heart failure. Eur J Heart Fail 2011;13:1161-1171
2. Aoyagi T Matsui T. The cardiomyocyte as a source of cytokines in cardiac injury. J Cell Sci Ther 2011;S5:1-3
3. Kai H Kuwahara F Tokuda K Imaizumi T. Diastolic dysfunction in hypertensive hearts: Roles of perivascular inflammation and reactive myocardial fibrosis. Hypertens Res 2005; 28:483-490
4. McCarthy CG Goulopoulou S Wenceslau CF Spitler KM Matsumoto T Webb RC. Toll-like receptors and damage-Associated molecular patterns: Novel links between inflammation and hypertension. Am J Physiol Heart Circ Physiol 2014;306:H184-H196
5. Mann DL. The emerging role of innate immunity in the heart and vascular system: For whom the cell tolls. Circ Res 2011;108:1133-1145
6. Shimano M Ouchi NWalsh K. Cardiokines: Recent progress in elucidating the cardiac secretome. Circulation 2012;126:e327-e332
7. Wilson EM Diwan A Spinale FG Mann DL. Duality of innate stress responses in cardiac injury repair and remodeling. J Mol Cell Cardiol 2004;37:801-811
8. Oyama J Blais C Jr Liu X Pu M Kobzik L Kelly RA et al. Reduced myocardial ischemia-reperfusion injury in toll-like receptor 4-deficient mice. Circulation 2004;109: 784-789
9. Timmers L Sluijter JP van Keulen JK Hoefer IE Nederhoff MG Goumans MJ et al. Toll-like receptor 4 mediates maladaptive left ventricular remodeling and impairs cardiac function after myocardial infarction. Circ Res 2008;102:257-264
10. Loukili N Rosenblatt-Velin N Li J Clerc S Pacher P Feihl F et al. Peroxynitrite induces HMGB1 release by cardiac cells in vitro and HMGB1 upregulation in the infarcted myocardium in vivo. Cardiovasc Res 2011;89:586-594
11. Takahashi K Fukushima S Yamahara K YashiroK ShintaniYCoppen SR et al. Modulated inflammation by injection of high-mobility group box 1 recovers post-infarction chronically failing heart. Circulation 2008;118:S106-S114
12. Schiraldi M Raucci A MunozLM Livoti E Celona B Venereau E et al.HMGB1 promotes recruitment of inflammatory cells to damaged tissues by forming a complex with CXCL12 and signaling via CXCR4. J Exp Med 2012;209:551-563
13. Singh MV Swaminathan PD Luczak ED KutschkeWWeiss RM Anderson ME. MyD88 mediated inflammatory signaling leads to CaMKII oxidation cardiac hypertrophy and death after myocardial infarction. J Mol Cell Cardiol 2012;52:1135-1144
14. Ling H Gray CB Zambon AC Grimm M Gu Y Dalton N et al. Ca2+/calmodulindependent protein kinase II delta mediates myocardial ischemia/reperfusion injury through nuclear factor-kappaB. Circ Res 2013;112:935-944
15. Felkin LE NaritaT Germack R ShintaniY Takahashi K Sarathchandra P et al. Calcineurin splicing variant calcineurin Abeta1 improves cardiac function after myocardial infarction without inducing hypertrophy. Circulation 2011;123:2838-2847
16. Kempf T Zarbock A Widera C Butz S Stadtmann A Rossaint J et al. GDF-15 is an inhibitor of leukocyte integrin activation required for survival after myocardial infarction in mice. Nat Med 2011;17:581-588
17. Takahashi M Nishihira J Shimpo M Mizue Y Ueno S Mano H et al. Macrophage migration inhibitory factor as a redox-sensitive cytokine in cardiac myocytes. Cardiovasc Res 2001;52:438-445
18. Fukuzawa J Nishihira J Hasebe N Haneda T Osaki J Saito T et al. Contribution of macrophage migration inhibitory factor to extracellular signal-regulated kinase activation by oxidative stress in cardiomyocytes. J Biol Chem 2002;277:24889-24895
19. Liehn EA Kanzler I Konschalla S Kroh A Simsekyilmaz S Sonmez TT et al. Compartmentalized protective and detrimental effects of endogenous macrophage migrationinhibitory factor mediated by CXCR2 in a mouse model of myocardial ischemia/ reperfusion. Arterioscler Thromb Vasc Biol 2013;33:2180-2186
20. Li N Lu X Zhao X Xiang FL Xenocostas A Karmazyn M et al. Endothelial nitric oxide synthase promotes bone marrowstromal cell migration to the ischemic myocardium via upregulation of stromal cell-derived factor-1alpha. Stem Cells 2009;27:961-970
21. Liehn EA Tuchscheerer N Kanzler I Drechsler M Fraemohs L Schuh A et al. Doubleedged role of the CXCL12/CXCR4 axis in experimental myocardial infarction. J Am Coll Cardiol 2011;58:2415-2423
22. Oka T Hikoso S Yamaguchi O Taneike M Takeda T Tamai T et al. MitochondrialDNA that escapes from autophagy causes inflammation and heart failure. Nature 2012;485: 251-255
23. Song X Kusakari Y Xiao CY Kinsella SD Rosenberg MA Scherrer-Crosbie M et al. mTOR attenuates the inflammatory response in cardiomyocytes and prevents cardiac dysfunction in pathological hypertrophy. Am J Physiol Cell Physiol 2010;299: C1256-C1266
24. CaiWF ZhangXW Yan HM Ma YGWang XX Yan J et al. Intracellular or extracellular heat shock protein 70 differentially regulates cardiac remodelling in pressure overload mice. Cardiovasc Res 2010;88:140-149
25. Xu H Su Z Wu J Yang M Penninger JM Martin CM et al. The alarmin cytokine high mobility group box 1 is produced by viable cardiomyocytes and mediates the lipopolysaccharide-induced myocardial dysfunction via a TLR4/ phosphatidylinositol 3-kinase gamma pathway. J Immunol 2010;184:1492-1498
26. Szabo-Fresnais N Lefebvre F Germain A Fischmeister R Pomerance M. A new regulation of IL-6 production in adult cardiomyocytes by beta-Adrenergic and IL-1 beta receptors and induction of cellular hypertrophy by IL-6 trans-signalling. Cell Signal 2010;22: 1143-1152
27. Peng T Lu X Lei M Moe GW Feng Q. Inhibition of p38 MAPK decreases myocardial TNF-Alpha expression and improves myocardial function and survival in endotoxemia. Cardiovasc Res 2003;59:893-900
28. PengT ZhangT LuX Feng Q. JNK1/c-fos inhibits cardiomyocyte TNF-Alpha expression via a negative crosstalk with ERK and p38 MAPK in endotoxaemia. Cardiovasc Res 2009; 81:733-741
29. Hall G Singh IS Hester L Hasday JD Rogers TB. Inhibitor-kappaB kinase-beta regulates LPS-induced TNF-Alpha production in cardiac myocytes through modulation of NF-kappaB p65 subunit phosphorylation. Am J Physiol Heart Circ Physiol 2005;289: H2103-H2111
30. Sun M Chen M DawoodF Zurawska U Li JY ParkerTet al. Tumor necrosis factor-Alpha mediates cardiac remodeling and ventricular dysfunction after pressure overload state. Circulation 2007;115:1398-1407
31. Bradham WS Bozkurt B Gunasinghe H Mann D Spinale FG. Tumor necrosis factoralpha and myocardial remodeling in progression of heart failure: A current perspective. Cardiovasc Res 2002;53:822-830
32. ZhangW Chancey AL Tzeng HP Zhou Z Lavine KJ Gao F et al. The development of myocardial fibrosis in transgenic mice with targeted overexpression of tumor necrosis factor requires mast cell-fibroblast interactions. Circulation 2011;124:2106-2116
33. Moe KT Yin NO Naylynn TM Khairunnisa K Wutyi MA Gu Y et al. Nox2 and Nox4 mediate tumour necrosis factor-Alpha-induced ventricular remodelling in mice. J Cell Mol Med 2011;15:2601-2613
34. Ock S Ahn J Lee SH Park H Son JW Oh JG et al. Receptor activator of nuclear factorkappaB ligand is a novel inducer of myocardial inflammation. Cardiovasc Res 2012;94: 105-114
35. Verma SK Krishnamurthy P Barefield D Singh N Gupta R Lambers E et al. Interleukin-10 treatment attenuates pressure overload-induced hypertrophic remodeling and improves heart function via signal transducers and activators of transcription 3-dependent inhibition of nuclear factor-kappaB. Circulation 2012;126:418-429
36. Venkatesan B Valente AJ Prabhu SD Shanmugam P Delafontaine P Chandrasekar B. EMMPRIN activates multiple transcription factors in cardiomyocytes and induces interleukin-18 expression via Rac1-dependent PI3K/Akt/IKK/NF-kappaB andMKK7/ JNK/AP-1 signaling. J Mol Cell Cardiol 2010;49:655-663
37. Schmidt R Bultmann A Fischel S Gillitzer A Cullen PWalchAet al. Extracellular matrix metalloproteinase inducer (CD147) is a novel receptor on platelets activates platelets and augments nuclear factor kappaB-dependent inflammation in monocytes. Circ Res 2008;102:302-309
38. Poffenberger MC Straka N El Warry N Fang D Shanina I Horwitz MS. Lack of IL-6 during coxsackievirus infection heightens the early immune response resulting in increased severity of chronic autoimmune myocarditis. PLoS ONE 2009;4:e6207
39. Shen Y XuW Chu YWWang Y Liu QS Xiong SD. Coxsackievirus group B type 3 infection upregulates expression of monocyte chemoattractant protein 1 in cardiac myocytes which leads to enhanced migration of mononuclear cells in viral myocarditis. J Virol 2004;78:12548-12556
40. Yuan J Liu Z Lim T Zhang H He J Walker E et al. CXCL10 inhibits viral replication through recruitment of natural killer cells in coxsackievirus B3-induced myocarditis. Circ Res 2009;104:628-638
41. Renault MA Robbesyn F Reant P Douin V Daret D Allieres C et al. Osteopontin expression in cardiomyocytes induces dilated cardiomyopathy. Circ Heart Fail 2010;3: 431-439
42. Yuen S Smith J Caruso L Balan M Opavsky MA. The coxsackie-Adenovirus receptor induces an inflammatory cardiomyopathy independent of viral infection. J Mol Cell Cardiol 2011;50:826-840
43. Caruso L Yuen S Smith J Husain M Opavsky MA. Cardiomyocyte-Targeted overexpression of the coxsackie-Adenovirus receptor causes a cardiomyopathy in association with beta-catenin signaling. J Mol Cell Cardiol 2010;48:1194-1205
44. Arslan F de KleijnDP PasterkampG. Innateimmune signaling in cardiac ischemia. Nat Rev Cardiol 2011;8:292-300
45. Bianchi ME. HMGB1 loves company. J Leukoc Biol 2009;86:573-576
46. Shimamoto A Chong AJ Yada M Shomura S Takayama H Fleisig AJ et al. Inhibition of Toll-like receptor 4 with eritoran attenuates myocardial ischemia-reperfusion injury. Circulation 2006;114:I270-I274
47. Gwechenberger M Mendoza LH Youker KA Frangogiannis NG SmithCW Michael LH et al. Cardiac myocytes produce interleukin-6 in culture and in viable border zone of reperfused infarctions. Circulation 1999;99:546-551
48. Yamauchi-Takihara K Ihara Y Ogata A Yoshizaki K Azuma J Kishimoto T. Hypoxic stress induces cardiac myocyte-derived interleukin-6. Circulation 1995;91:1520-1524
49. Hilfiker-Kleiner D Shukla P Klein G Schaefer A Stapel B Hoch M et al. Continuous glycoprotein-130-mediated signal transducer and activator of transcription-3 activation promotes inflammation left ventricular rupture and adverse outcome in subacute myocardial infarction. Circulation 2010;122:145-155
50. Hilfiker-Kleiner D Hilfiker A Fuchs M Kaminski K Schaefer A Schieffer B et al. Signal transducer and activator of transcription 3 is required for myocardial capillary growth control of interstitial matrix deposition and heart protection from ischemic injury. Circ Res 2004;95:187-195
51. Dahl CP Husberg C Gullestad LWaehre A Damas JK Vinge LE et al. Increased production of CXCL16 in experimental and clinical heart failure: A possible role in extracellular matrix remodeling. Circ Heart Fail 2009;2:624-632
52. Kempf T Eden M Strelau J Naguib M Willenbockel C Tongers J et al. The transforming growth factor-beta superfamily member growth-differentiation factor-15 protects the heart from ischemia/reperfusion injury. Circ Res 2006;98:351-360
53. van Berlo JH Maillet M Molkentin JD. Signaling effectors underlying pathologic growth and remodeling of the heart. J Clin Invest 2013;123:37-45
54. Hennessy EJ Parker AE ONeill LA. Targeting Toll-like receptors: Emerging therapeutics?. Nat Rev Drug Discov 2010;9:293-307
55. Velten M Duerr GD Pessies T Schild J Lohner R Mersmann J et al. Priming with synthetic oligonucleotides attenuates pressure overload-induced inflammation and cardiac hypertrophy in mice. Cardiovasc Res 2012;96:422-432
56. Tian J Guo X Liu XM Liu L Weng QF Dong SJ et al. Extracellular HSP60 induces inflammation through activating and up-regulating TLRs in cardiomyocytes. Cardiovasc Res 2013;98:391-401
57. Perino A Ghigo A Ferrero E Morello F Santulli G BaillieGSet al. Integrating cardiac PIP3 and cAMP signaling through a PKA anchoring function of p110gamma. Mol Cell 2011;42: 84-95
58. Ghigo A Perino A Mehel H ZahradnikovaAJr Morello F Leroy J et al. Phosphoinositide 3-kinase gamma protects against catecholamine-induced ventricular arrhythmia through protein kinase A-mediated regulation of distinct phosphodiesterases. Circulation 2012; 126:2073-2083
59. Bristow MR Ginsburg R Minobe W Cubicciotti RS Sageman WS Lurie K et al. Decreased catecholamine sensitivity and beta-Adrenergic-receptor density in failing human hearts. N Engl J Med 1982;307:205-211
60. Damilano F Franco I Perrino C Schaefer K Azzolino O Carnevale D et al. Distinct effects of leukocyte and cardiac phosphoinositide 3-kinase gamma activity in pressure overload-induced cardiac failure. Circulation 2011;123:391-399
61. Pellieux C Montessuit C Papageorgiou I Lerch R. Angiotensin II downregulates the fatty acid oxidation pathway in adult rat cardiomyocytes via release of tumour necrosis factoralpha. Cardiovasc Res 2009;82:341-350
62. Wang X Khaidakov M Ding Z Mitra S Lu J Liu S et al. Cross-Talk between inflammation and angiotensin II: Studies based on Direct transfection of cardiomyocytes withAT1R and AT2R cDNA. Exp Biol Med (Maywood) 2012;237:1394-1401
63. PengT Shen E Fan J ZhangY Arnold JM Feng Q. Disruption of phospholipaseCgamma1 signalling attenuates cardiac tumor necrosis factor-Alpha expression and improves myocardial function During endotoxemia. Cardiovasc Res 2008;78:90-97
64. Zhu H Shan L Schiller PW Mai A Peng T. Histone deacetylase-3 activation promotes tumor necrosis factor-Alpha (TNF-Alpha) expression in cardiomyocytes during lipopolysaccharide stimulation. J Biol Chem 2010;285:9429-9436
65. Geoghegan-Morphet N Burger D Lu X SathishV PengT SimsSMet al. Role of neuronal nitric oxide synthase in lipopolysaccharide-induced tumor necrosis factor-Alpha expression in neonatal mouse cardiomyocytes. Cardiovasc Res 2007;75:408-416
66. Zhang T Lu X Arnold P Liu Y Baliga R Huang H et al. Mitogen-Activated protein kinase phosphatase-1 inhibits myocardial TNF-Alpha expression and improves cardiac function During endotoxemia. Cardiovasc Res 2012;93:471-479
67. Shen E Fan J Peng T. Glycogen synthase kinase-3beta suppresses tumor necrosis factoralpha expression in cardiomyocytes during lipopolysaccharide stimulation. J Cell Biochem 2008;104:329-338
68. Fallach R Shainberg A Avlas O Fainblut M Chepurko Y Porat E et al. Cardiomyocyte Toll-like receptor 4 is involved in heart dysfunction following septic shock or myocardial ischemia. J Mol Cell Cardiol 2010;48:1236-1244
69. Levine B Kalman J Mayer L Fillit HM Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 1990;323:236-241
70. Mann DL McMurray JJ Packer M Swedberg K Borer JS Colucci WS et al. Targeted anticytokine therapy in patients with chronic heart failure: Results of the Randomized EtanerceptWorldwide Evaluation (RENEWAL). Circulation 2004;109:1594-1602
71. Chung ES Packer M Lo KH Fasanmade AA Willerson JT. Randomized double-blind placebo-controlled pilot trial of infliximab a chimeric monoclonal antibody to tumor necrosis factor-Alpha in patients with moderate-To-severe heart failure: Results of the anti-TNF Therapy Against Congestive Heart Failure (ATTACH) trial. Circulation 2003; 107:3133-3140
72. Kurrelmeyer KM Michael LH Baumgarten G Taffet GE Peschon JJ Sivasubramanian N et al. Endogenous tumor necrosis factor protects the adult cardiac myocyte against ischemic-induced apoptosis in a murine model of acute myocardial infarction. Proc Natl Acad Sci USA 2000;97:5456-5461
73. Siwik DA Kuster GM Brahmbhatt JV Zaidi Z Malik J Ooi H et al. EMMPRIN mediates beta-Adrenergic receptor-stimulated matrix metalloproteinase activity in cardiac myocytes. J Mol Cell Cardiol 2008;44:210-217
74. Kaur K Sharma AK Dhingra S Singal PK. Interplay of TNF-Alpha and IL-10 in regulating oxidative stress in isolated adult cardiac myocytes. J Mol Cell Cardiol 2006;41:1023-1030
75. Frangogiannis NG. Regulation of the inflammatory response in cardiac repair. Circ Res 2012;110:159-173
76. Sagar S Liu PP Cooper LT Jr. Myocarditis. Lancet 2012;379:738-747
77. Cooper LT Jr. Myocarditis. N Engl J Med 2009;360:1526-1538
78. Herskowitz A Ahmed-Ansari A Neumann DA Beschorner WE Rose NR Soule LM et al. Induction of major histocompatibility complex antigens within the myocardium of patients with active myocarditis: A nonhistologic marker of myocarditis. J Am Coll Cardiol 1990;15:624-632
79. Ritter JT Tang-Feldman YJ Lochhead GR Estrada M Lochhead S YuCet al. In vivo characterization of cytokine profiles and viral load during murine cytomegalovirus-induced acute myocarditis. Cardiovasc Pathol 2010;19:83-93
80. Kubota T McTiernan CF Frye CS Demetris AJ Feldman AM. Cardiac-specific overexpression of tumor necrosis factor-Alpha causes lethal myocarditis in transgenic mice. J Card Fail 1997;3:117-124
81. Reifenberg K Lehr HA Torzewski M Steige G Wiese E Kupper I et al. Interferon-gamma induces chronic active myocarditis and cardiomyopathy in transgenic mice. Am J Pathol 2007;171:463-472
82. Torzewski M Wenzel P Kleinert H Becker C El-Masri J Wiese E et al. Chronic inflammatory cardiomyopathy of interferon gamma-overexpressing transgenic mice is mediated by tumor necrosis factor-Alpha. Am J Pathol 2012;180:73-81
83. Lane JR Neumann DA Lafond-Walker A Herskowitz A Rose NR. Role of IL-1 and tumor necrosis factor in coxsackie virus-induced autoimmune myocarditis. J Immunol 1993;151:1682-1690
84. Li K XuW Guo Q Jiang ZWang P Yue Y et al. Differential macrophage polarization in male and female BALB/c mice infected with coxsackievirus B3 defines susceptibility to viral myocarditis. Circ Res 2009;105:353-364
85. Szalay G Sauter M Hald J Weinzierl A Kandolf R Klingel K. Sustained nitric oxide synthesis contributes to immunopathology in ongoing myocarditis attributable to interleukin-10 disorders. Am J Pathol 2006;169:2085-2093
86. Kanda T McManus JE Nagai R Imai S Suzuki T Yang D et al. Modification of viral myocarditis in mice by interleukin-6. Circ Res 1996;78:848-856
87. Tanaka T Kanda TMcManus BM Kanai H Akiyama H Sekiguchi K et al. Overexpression of interleukin-6 aggravates viral myocarditis: Impaired increase in tumor necrosis factoralpha. J Mol Cell Cardiol 2001;33:1627-1635
88. Mann DL. Interleukin-6 and viral myocarditis: The Yin-Yang of cardiac innate immune responses. J Mol Cell Cardiol 2001;33:1551-1553
89. Lindner D Hilbrandt M Marggraf K Becher PM Hilfiker-Kleiner D Klingel K et al. Protective function of STAT3 in CVB3-induced myocarditis. Cardiol Res Pract 2012;2012: 437623
90. Kobara M Noda K Kitamura M Okamoto A Shiraishi T Toba H et al. Antibody against interleukin-6 receptor attenuates left ventricular remodelling after myocardial infarction in mice. Cardiovasc Res 2010;87:424-430
91. Camporeale A Marino F Papageorgiou A Carai P Fornero S Fletcher S et al. STAT3 activity is necessary and sufficient for the development of immune-mediated myocarditis in mice and promotes progression to dilated cardiomyopathy. EMBO Mol Med 2013;5: 572-590
92. Szalay G Sauter M Haberland M Zuegel U Steinmeyer A KandolfRet al. Osteopontin: A fibrosis-related marker molecule in cardiac remodeling of enterovirus myocarditis in the susceptible host. Circ Res 2009;104:851-859
93. Esfandiarei M McManus BM. Molecular biology and pathogenesis of viral myocarditis. Annu Rev Pathol 2008;3:127-155
94. Shi Y Chen C Lisewski U Wrackmeyer U Radke M Westermann D et al. Cardiac deletion of the coxsackievirus-Adenovirus receptor abolishes coxsackievirus B3 infection and prevents myocarditis in vivo. J Am Coll Cardiol 2009;53: 1219-1226
95. Ruppert V Meyer T Pankuweit S Jonsdottir T Maisch B. Activation of STAT1 transcription factor precedes up-regulation of coxsackievirus-Adenovirus receptor during viral myocarditis. Cardiovasc Pathol 2008;17:81-92